Lisa Lagorgette - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Lisa Lagorgette

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Cell Death & Disease|December 20, 2024

PP2C phosphatases-terminators of suicidal thoughtsLisa Lagorgette, Daria A Bogdanova, Ekaterina V Belotserkovskaya, et al.

Nature Communications|June 16, 2021

Inhibition of the DNA damage response phosphatase PPM1D reprograms neutrophils to enhance anti-tumor immune responsesBurhan Uyanik, Anastasia R Goloudina, Aamir Akbarali, et al.

Cell Death & Disease|May 18, 2026

Combining PD-L1 blockade with a second-generation HSP110 inhibitor enhances antitumor immunity in colorectal cancerMaría Jimena Abrey-Recalde, Flavie Mialhe, Thi Khanh Le, et al.

Pageof 1

Search research articles

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Cell Death & Disease|December 20, 2024

PP2C phosphatases-terminators of suicidal thoughtsLisa Lagorgette, Daria A Bogdanova, Ekaterina V Belotserkovskaya, et al.

Nature Communications|June 16, 2021

Inhibition of the DNA damage response phosphatase PPM1D reprograms neutrophils to enhance anti-tumor immune responsesBurhan Uyanik, Anastasia R Goloudina, Aamir Akbarali, et al.

Cell Death & Disease|May 18, 2026

Combining PD-L1 blockade with a second-generation HSP110 inhibitor enhances antitumor immunity in colorectal cancerMaría Jimena Abrey-Recalde, Flavie Mialhe, Thi Khanh Le, et al.

Pageof 1